How have CITE shares performed in 2024?

Cartica Acquisition's stock was trading at $10.91 on January 1st, 2024. Since then, CITE stock has increased by 2.7% and is now trading at $11.20. View the best growth stocks for 2024 here .

Are investors shorting Cartica Acquisition?

Cartica Acquisition saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 3,400 shares, an increase of 6.3% from the March 31st total of 3,200 shares. Based on an average daily volume of 23,300 shares, the short-interest ratio is currently 0.1 days. Currently, 0.1% of the shares of the stock are sold short. View Cartica Acquisition's Short Interest .

How do I buy shares of Cartica Acquisition?

Shares of CITE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CITE

Cartica Acquisition (CITE) Stock Price, News & Analysis

→ Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad)

Free CITE Stock Alerts

$11.20

+0.06 (+0.54%)

(As of 04:30 PM ET)

Compare

Today's Range: $11.14
▼
$12.25
50-Day Range: $10.96
▼
$11.20
52-Week Range: $10.34
▼
$12.67

Volume: 4,400 shs
Average Volume: 33,722 shs
Market Capitalization: $111.55 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines Ownership SEC Filings Short Interest Social Media

Get Cartica Acquisition alerts:

Ad Stansberry Research

Mysterious Gold Leverage Just Announced

World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.

Find out what it is and see how you can get in with just a few dollars.

About Cartica Acquisition Stock (NASDAQ:CITE)

Cartica Acquisition Corp does not have any significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and complete a business combination in the technology sector in India. Cartica Acquisition Corp was incorporated in 2021 and is based in Washington, the District of Columbia.

CITE Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CITE Stock News Headlines

February 6, 2024 | finance.yahoo.com

Owning 48% shares,institutional owners seem interested in Cartica Acquisition Corp (NASDAQ:CITE),

See More Headlines

Receive CITE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cartica Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/25/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Unclassified
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:CITE
CUSIP: N/A
CIK: 1848437
Web: carticaspac.com
Phone: 202-367-3003
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 9,960,000
Free Float: 4,514,000
Market Cap: $111.55 million
Optionable: Not Optionable
Beta: 0.02

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Suresh Guduru (Age 50)
CEO & Chairman
Mr. Chad Brian Coad C.F.A. (Age 54)
COO & CFO
Mr. Suresh Singamsetty (Age 49)
Chief Investment Officer & Director

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

CITE Stock Analysis - Frequently Asked Questions

How have CITE shares performed in 2024?: Cartica Acquisition's stock was trading at $10.91 on January 1st, 2024. Since then, CITE stock has increased by 2.7% and is now trading at $11.20.
View the best growth stocks for 2024 here.
Are investors shorting Cartica Acquisition?: Cartica Acquisition saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 3,400 shares, an increase of 6.3% from the March 31st total of 3,200 shares. Based on an average daily volume of 23,300 shares, the short-interest ratio is currently 0.1 days. Currently, 0.1% of the shares of the stock are sold short.
View Cartica Acquisition's Short Interest.
How do I buy shares of Cartica Acquisition?: Shares of CITE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CITE) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial